Explainable, Fair, Reproducible and Collaborative Surgical Artificial Intelligence: Integrating data, algorithms and clinical reasoning for surgical risk assessment (XAI-IDEALIST)
Explainable, Fair, Reproducible and Collaborative Surgical Artificial Intelligence: Integrating data, algorithms and clinical reasoning for surgical risk assessment (XAI-IDEALIST)
批准号:
10681418
负责人:
Azra Bihorac
金额:
$54.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-03-01 至 2026-05-31
关键词:
AccelerationAddressAdoptedAlgorithmsAmericanArtificial IntelligenceArtificial Intelligence platformBehavioralBenchmarkingBridge to Artificial IntelligenceClinicalClinical ResearchClinical TrialsCognitiveCollaborationsComplicationComputing MethodologiesCritical CareDataData PoolingData SetEarly InterventionEnvironmentEthicsEvaluationFloridaFoundationsFundingGenerationsHealthHospital CostsHospitalizationHospitalsHumanInformaticsInfrastructureInstitutionIntelligenceInvestmentsLegal patentMachine LearningMedicalMindMissionModelingOperative Surgical ProceduresPatient CarePatient-Focused OutcomesPatientsPerformancePerioperative CarePhysiciansPhysiologicalPopulation HeterogeneityPostoperative ComplicationsPrevention strategyPrivacyProcessProductivityPsyche structurePublic HealthPublicationsReproducibilityResearchRiskRisk AssessmentScienceSystemTechnologyTestingTimeTrainingTrustUnited StatesUnited States National Institutes of HealthUniversitiesValidationWorkadvanced diseaseclinical implementationcollaborative approachcomputerized toolsdata integrationdata modelingdata sharingdata streamsdisease diagnosisdistributed dataeffectiveness evaluationfederated learninghigh riskhuman centered computingimprovedinnovationinteroperabilitymachine learning algorithmmultimodal datamultimodalitynoveloperationpreferenceprivacy preservationprogramsprospectiveprospective testrisk mitigationsocial health determinantssuccesssurgical risktheoriestooltrustworthinessusability
中文摘要
项目摘要
在美国,平均每个美国人一生中要做七次手术。
每年有15万名手术患者死亡,150万人在手术后出现并发症。取得的进展
医学人工智能(AI)仍然因为有限的数据集和解释不足的模型而停滞不前,
透明度、公平性和再现性,这些都是难以实施和跨机构共享的。在
此前资助期内,除98项出版物和3项专利外,还有一项实时智能手术风险
该评估体系已在佛罗里达大学成功实施。这样做的总体目标是
续订申请是为了开发一个新的概念性框架,以实现可解释、公平、可重现和
协作式医疗AI“,为规模化的临床实施提供基础。它将利用
One佛罗里达,一个由22家医院组成的大型临床联盟,为佛罗里达州的1000万患者提供服务,这是全国第三大临床联盟
最大的州。总体目标将通过追求三个具体目标来实现。
(1)新的可解释、动态、可操作、公平和可复制的外部和预期验证
用于实时手术风险监控的算法工具包。(2)开发和评估可解释的AI平台
(Xai-理想主义者),使用人类接地基准进行实时手术风险监测。(三)落实
以及针对协作手术风险评估具有高级隐私特征的联合学习方法
模特儿训练。这种方法是创新的,因为它代表了(1)建造第一个外科手术的第一次尝试
公平(可查找、可访问、可互操作、可重现)支持人工智能的大型多中心多模式数据集,(2)
伴随着评估公平性和重复性的新的计算方法,(3)多方面的
和全栈可解释人工智能框架,以及(4)隐私保护模型的联合学习能力
跨机构培训。拟议的研究具有重要意义,因为它将解决几个关键问题和
关键障碍,包括(1)缺乏支持人工智能的大型外科数据集,(2)缺乏可解释的、动态的、
可操作、公平和可重复的手术风险算法,(2)缺乏医疗AI可解释平台,以及(4)
缺乏一种系统的方法,以便在各机构之间进行协作模式培训和分享。归根结底,
预计结果将改善患者的预后,降低住院费用,以及终生
并发症。
英文摘要
Project Summary
In the United States, the average American can expect to undergo seven surgical operations during a lifetime.
Each year 150,000 surgical patients die, and 1.5 million develop a complication after surgery. Progress in
medical Artificial Intelligence (AI) remains halted by limited datasets and models with insufficient interpretability,
transparency, fairness, and reproducibility that are difficult to implement and share across institutions. In the
previous funding period, in addition to 98 publications and 3 patents, a real-time intelligent surgical risk
assessment system was successfully implemented at University of Florida. The overall objective of this
renewal application is to develop a new conceptual framework for “Explainable, Fair, Reproducible, and
Collaborative Medical AI” to provide a foundation for clinical implementation at scale. It will leverage the
OneFlorida, a large clinical consortium of 22 hospitals serving 10 million patients in Florida, the nation’s third
largest state. The overall objective will be achieved by pursuing three specific aims.
(1) External and prospective validation of novel interpretable, dynamic, actionable, fair and reproducible
algorithmic toolkit for real-time surgical risk surveillance. (2) Developing and evaluating explainable AI platform
(XAI-IDEALIST) for real-time surgical risk surveillance using human-grounded benchmarks. (3) Implementing
and evaluating a federated learning approach with advanced privacy features for collaborative surgical risk
model training. The approach is innovative, because it represents the first attempt to (1) build the first surgical
FAIR (Findable, Accessible, Interoperable, Reproducible) AI-ready, large multicenter multimodal dataset, (2)
Novel computational approaches accompanied by assessing fairness and reproducibility, (3) a multifaceted
and full-stack explainable AI framework, and (4) federated learning capacity for privacy-preserving model
trainingacross institutions. The proposed research is significant since it will address several key problems and
critical barriers, including (1) lack of AI-ready large surgical datasets, (2) lack of interpretable, dynamic,
actionable, fair and reproducible surgical risk algorithms, (2) lack of a medical AI explainability platform, and (4)
lack of a systematic approach for collaborative model training and sharing across institutions. Ultimately, the
results are expected to improve patient outcomes and decrease hospitalization costs, as well as lifelong
complications.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kidney and Brain, an Unbroken Chain.
肾脏和大脑,一条不间断的链条。
DOI:
10.1164/rccm.201611-2371ed
发表时间:
2017
期刊:
American journal of respiratory and critical care medicine
影响因子:
24.7
作者:
[Bihorac,Azra, Hobson,Charles]
通讯作者:
Hobson,Charles
DOI:
10.1097/sla.0000000000003935
发表时间:
2021-02-01
期刊:
Annals of surgery
影响因子:
9
作者:
[Khan TA, Loftus TJ, Filiberto AC, Ozrazgat-Baslanti T, Ruppert MM, Bandyopadhyay S, Laiakis EC, Arnaoutakis DJ, Bihorac A]
通讯作者:
Bihorac A
Cardiac and Vascular Surgery-Associated Acute Kidney Injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group.
心脏和血管外科相关的急性肾脏损伤:第20届ADQI国际共识会议(急性疾病质量倡议)小组。
DOI:
10.1161/jaha.118.008834
发表时间:
2018-06-01
期刊:
Journal of the American Heart Association
影响因子:
5.4
作者:
[Nadim MK, Forni LG, Bihorac A, Hobson C, Koyner JL, Shaw A, Arnaoutakis GJ, Ding X, Engelman DT, Gasparovic H, Gasparovic V, Herzog CA, Kashani K, Katz N, Liu KD, Mehta RL, Ostermann M, Pannu N, Pickkers P, Price S, Ricci Z, Rich JB, Sajja LR, Weaver FA, Zarbock A, Ronco C, Kellum JA]
通讯作者:
Kellum JA
Computable Phenotypes to Characterize Changing Patient Brain Dysfunction in the Intensive Care Unit.
可计算表型来表征重症监护病房中不断变化的患者脑功能障碍。
DOI:
--
发表时间:
2023
期刊:
ArXiv
影响因子:
--
作者:
[Ren,Yuanfang, Loftus,TylerJ, Guan,Ziyuan, Uddin,Rayon, Shickel,Benjamin, Maciel,CarolinaB, Busl,Katharina, Rashidi,Parisa, Bihorac,Azra, Ozrazgat-Baslanti,Tezcan]
通讯作者:
Ozrazgat-Baslanti,Tezcan
The Pattern of Longitudinal Change in Serum Creatinine and 90-Day Mortality After Major Surgery.
大手术后血清肌酐和 90 天死亡率的纵向变化模式。
DOI:
10.1097/sla.0000000000001362
发表时间:
2016-06
期刊:
Annals of surgery
影响因子:
9
作者:
[Korenkevych D, Ozrazgat-Baslanti T, Thottakkara P, Hobson CE, Pardalos P, Momcilovic P, Bihorac A]
通讯作者:
Bihorac A
共 21 条
Bridge2AI: Patient-Focused Collaborative Hospital Repository Uniting Standards (CHoRUS) for Equitable AI
-
批准号:10858694
-
项目类别:
-
资助金额:$637.03万
-
财政年份:2022
-
负责人:Azra Bihorac
-
依托单位:
Bridge2AI: Patient-Focused Collaborative Hospital Repository Uniting Standards (CHoRUS) for Equitable AI
-
批准号:10472824
-
项目类别:
-
资助金额:$588.03万
-
财政年份:2022
-
负责人:Azra Bihorac
-
依托单位:
(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI
-
批准号:10414976
-
项目类别:
-
资助金额:$63.05万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI
-
批准号:10594086
-
项目类别:
-
资助金额:$27.89万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention
-
批准号:10396041
-
项目类别:
-
资助金额:$59.9万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI
-
批准号:10609525
-
项目类别:
-
资助金额:$63.56万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention
-
批准号:10178157
-
项目类别:
-
资助金额:$61.26万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
Intelligent Intensive Care Unit (I2CU): Pervasive Sensing and Artificial Intelligence for Augmented Clinical Decision-making
-
批准号:10154047
-
项目类别:
-
资助金额:$63.21万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI
-
批准号:10209005
-
项目类别:
-
资助金额:$56.22万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
Intelligent Intensive Care Unit (I2CU): Pervasive Sensing and Artificial Intelligence for Augmented Clinical Decision-making
-
批准号:10580785
-
项目类别:
-
资助金额:$60.06万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
Intelligent Intensive Care Unit (I2CU): Pervasive Sensing and Artificial Intelligence for Augmented Clinical Decision-making
-
批准号:10374834
-
项目类别:
-
资助金额:$59.49万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention
-
批准号:10602426
-
项目类别:
-
资助金额:$55.72万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
Explainable, Fair, Reproducible and Collaborative Surgical Artificial Intelligence: Integrating data, algorithms and clinical reasoning for surgical risk assessment (XAI-IDEALIST)
-
批准号:10445486
-
项目类别:
-
资助金额:$55.49万
-
财政年份:2016
-
负责人:Azra Bihorac
-
依托单位:
Integrating data, algorithms and clinical reasoning for surgical risk assessment
-
批准号:9233163
-
项目类别:
-
资助金额:$53.14万
-
财政年份:2016
-
负责人:Azra Bihorac
-
依托单位:
PROMISES: Progenitor Endothelial Cells as a Marker of Endothelial Injury and Repa
-
批准号:8280337
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2010
-
负责人:Azra Bihorac
-
依托单位:
PROMISES: Progenitor Endothelial Cells as a Marker of Endothelial Injury and Repa
-
批准号:8076251
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2010
-
负责人:Azra Bihorac
-
依托单位:
PROMISES: Progenitor Endothelial Cells as a Marker of Endothelial Injury and Repa
-
批准号:8496075
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2010
-
负责人:Azra Bihorac
-
依托单位:
PROMISES: Progenitor Endothelial Cells as a Marker of Endothelial Injury and Repa
-
批准号:7787562
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2010
-
负责人:Azra Bihorac
-
依托单位:
海外基金